Rostami Research Technologies Inc.

Corporate profile

Rostami Research Technologies Inc.

A Canadian software company building research data-collection and analysis tools for academic and clinical researchers.

What we build

RRT Inc. develops software for collecting and analyzing research data. Our work is aimed at researchers who administer structured instruments — questionnaires, validated scales, and interview protocols — to participants and need the results in a form they can analyze and publish.

Now, we operate a single product, myquestionnaire.ai, which lets researchers upload or build a questionnaire, collect responses via an online form or an AI-conducted interview, and analyze the results using standard psychometric statistics.

Who we serve

Academic researchers, clinicians administering validated instruments, market researchers, and the universities, hospitals, and research institutes they work within. Our users are typically bound by their own ethics approvals and institutional data policies, which shapes how we build.

How we handle data

Research data is stored in Canada. Our platform is designed for processing aligned with GDPR and PIPEDA, with the researcher acting as data controller and RRT Inc. as processor. Participants take part through single-use, expiring links rather than accounts.

Our full security posture is published at myquestionnaire.ai/security.

Company

RRT Inc. is federally incorporated in Canada with its registered office in Calgary, Alberta. The company was founded and is operated by Mahdi Rostami Haji Abadi.

For business, partnership, or compliance enquiries, see contact.

Corporate record Active
Legal name
Rostami Research Technologies Inc.
Operating as
RRT Inc.
Entity type
Business corporation
Jurisdiction
Canada — federal incorporation
Corporation number
1805009-1
Date of incorporation
26 June 2026
Filing status
Active
Registered office
Calgary, Alberta, Canada
General contact

Verifiable against the federal register at Corporations Canada using corporation number 1805009-1.